Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles S Foster

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Opinion in Ophthalmology|October 16, 2009
Cataracts and uveitisMaria Jancevski, Charles S Foster
Retinal Cases & Brief Reports|October 7, 2021
NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORTCristina M Garcia, Arash Maleki, Sydney Look-Why, et al.
European Journal of Ophthalmology|June 25, 2009
Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-upRene A Cervantes-Castañeda, Gian Paolo Giuliari, Michael J Gallagher, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Opinion in Ophthalmology|October 16, 2009
Cataracts and uveitisMaria Jancevski, Charles S Foster
Retinal Cases & Brief Reports|October 7, 2021
NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORTCristina M Garcia, Arash Maleki, Sydney Look-Why, et al.
European Journal of Ophthalmology|June 25, 2009
Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-upRene A Cervantes-Castañeda, Gian Paolo Giuliari, Michael J Gallagher, et al.
Pageof 1